UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000006513
Receipt number	R000007719
Scientific Title	Phase 1/2 study of the combination of Bendamustine and Rituximab for treatment of elderly relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.
Date of disclosure of the study information	2011/10/18
Last modified on	2011/10/10 15:34:26

---